Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1960 Jul;39(7):1091–1106. doi: 10.1172/JCI104124

ALDOSTERONE SECRETION AND PRIMARY AND MALIGNANT HYPERTENSION *

John H Laragh 1,2,3,4,5, Stanley Ulick 1,2,3,4,5, Vlodzimierz Januszewicz 1,2,3,4,5, Quentin B Deming 1,2,3,4,5, William G Kelly 1,2,3,4,5, Seymour Lieberman 1,2,3,4,5
PMCID: PMC441854  PMID: 14414161

Full text

PDF
1094

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTTER F. C., BIGLIERI E. G. Primary aldosteronism: clinical staff conference at the National Institutes of Health. Ann Intern Med. 1958 Mar;48(3):647–654. doi: 10.7326/0003-4819-48-3-647. [DOI] [PubMed] [Google Scholar]
  2. BROOKS R. V., McSWINEY R. R., PRUNTY F. T., WOOD F. J. Potassium deficiency of renal and adrenal origin. Am J Med. 1957 Sep;23(3):391–407. doi: 10.1016/0002-9343(57)90319-4. [DOI] [PubMed] [Google Scholar]
  3. CONN J. W. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955 Jan;45(1):3–17. [PubMed] [Google Scholar]
  4. DOORENBOS H., ELINGS H. S., VAN BUCHEM F. S. Primary aldosteronism due to adrenocortical hyperplasia. Lancet. 1956 Aug 18;271(6938):335–337. doi: 10.1016/s0140-6736(56)92194-8. [DOI] [PubMed] [Google Scholar]
  5. EALES L., LINDER G. C. Potassium-losing pyelonephritis and malignant hypertension: a case report with balance studies. Metabolism. 1959 Jul 1;8(4 Pt 1):445–454. [PubMed] [Google Scholar]
  6. FITZGERALD M. G., FOURMAN P., JAMES A. H., SCARBOROUGH H. Malignant hypertension, adrenal hyperplasia and depletion of potassium. Scott Med J. 1957 Dec;2(12):473–475. doi: 10.1177/003693305700201205. [DOI] [PubMed] [Google Scholar]
  7. FLYNN P. Adrenal cortical tumour with fulminating hypertension. J Ir Med Assoc. 1956 Sep;39(231):77–80. [PubMed] [Google Scholar]
  8. FOYE L. V., Jr, FEICHTMEIR T. V. Adrenal cortical carcinoma producing solely mineralocorticoid effect. Am J Med. 1955 Dec;19(6):966–975. doi: 10.1016/0002-9343(55)90163-7. [DOI] [PubMed] [Google Scholar]
  9. FRIEDMAN S. M., FRIEDMAN C. L., NAKASHIMA M. Sustained hypertension following the administration of desoxycorticosterone acetate. J Exp Med. 1951 Apr 1;93(4):361–372. doi: 10.1084/jem.93.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GENEST J., KOIW E., NOWACZYNSKI W., LEBOEUF G. Further studies on urinary aldosterone in human arterial hypertension. Proc Soc Exp Biol Med. 1958 Mar;97(3):676–679. doi: 10.3181/00379727-97-23843. [DOI] [PubMed] [Google Scholar]
  11. HILTON J. G., WESTERMANN C. D., BERGEN S. S., CRAMPTON R. S. Syndrome of mineralocorticoid excess due to bilateral adrenocortical hyperplasia; report of a case. N Engl J Med. 1959 Jan 29;260(5):202–205. doi: 10.1056/NEJM195901292600502. [DOI] [PubMed] [Google Scholar]
  12. HOLTEN C., PETERSEN V. P. Malignant hypertension with increased secretion of aldosterone and depletion of potassium. Lancet. 1956 Nov 3;271(6949):918–922. doi: 10.1016/s0140-6736(56)90383-x. [DOI] [PubMed] [Google Scholar]
  13. KNOWLTON A. I., LOEB E. N. The development of hypertension and nephritis in normal and adrenalectomized rats treated with cortisone. Proc Soc Exp Biol Med. 1949 Dec;72(3):722–725. doi: 10.3181/00379727-72-17556. [DOI] [PubMed] [Google Scholar]
  14. LARAGH J. H. Aldosterone in fluid and electrolyte disorders: hyper- and hypoaldosteronism. J Chronic Dis. 1960 Mar;11:292–318. doi: 10.1016/0021-9681(60)90041-2. [DOI] [PubMed] [Google Scholar]
  15. LARAGH J. H. The effect of potassium chloride on hyponatremia. J Clin Invest. 1954 May;33(5):807–818. doi: 10.1172/JCI102952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MELLINGER R., THERIAN B., KLINE I. T., DITZLER J., SMITH R., FINE G. Primary aldosteronism. Henry Ford Hosp Med Bull. 1958 Mar;6(1):1–10. [PubMed] [Google Scholar]
  17. RIFKIN H., SOLOMON S., LIEBERMAN S. Role of the adrenal cortex in diabetic retinopathy and nephropathy. Diabetes. 1958 Jan-Feb;7(1):9–14. doi: 10.2337/diab.7.1.9. [DOI] [PubMed] [Google Scholar]
  18. SIMPSON S. A., TAIT J. F., WETTSTEIN A., NEHER R., VON EUW J., REICHSTEIN T. Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel. Experientia. 1953 Sep;9(9):333–335. doi: 10.1007/BF02155834. [DOI] [PubMed] [Google Scholar]
  19. Selye H., Hall C. E., Rowley E. M. Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride. Can Med Assoc J. 1943 Aug;49(2):88–92. [PMC free article] [PubMed] [Google Scholar]
  20. TOBIAN L., Jr, BINION J. T. Tissue cations and water in arterial hypertension. Circulation. 1952 May;5(5):754–758. doi: 10.1161/01.cir.5.5.754. [DOI] [PubMed] [Google Scholar]
  21. ULICK S., LARAGH J. H., LIEBERMAN S. The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man. Trans Assoc Am Physicians. 1958;71:225–235. [PubMed] [Google Scholar]
  22. WYNGAARDEN J. B., KEITEL H. G., ISSELBACHER K. Potassium depletion and alkalosis; their association with hypertension and renal insufficiency. N Engl J Med. 1954 Apr 8;250(14):597–600. doi: 10.1056/NEJM195404082501403. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES